Call For Applications | ACC 2026 Leadership Forum Chair – American College of Cardiology
Call For Applications | ACC 2026 Leadership Forum Chair
Related Articles
CereVasc’s eShunt Evaluated in Pilot Study of Elderly Patients With NPH – Endovascular Today
February 5, 2025—CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the tre
Welcome! You are invited to join a webinar: Behind the Scenes: Navigating Peer Review and Revisions at Circulation: Cardiovascular Imaging. After registering, you will receive a confirmation email about joining the webinar.
The Circulation: Cardiovascular Imaging Section Editors for Digital Media Strategies, Jiwon Kim and Kazuaki Negishi, will host our latest webinar offering. This webinar will provide…
Be good to your teeth: Regular flossing reduces risk of stroke, AFib
The difference in atrial fibrillation risk was unexpected, surprising researchers.
Author Hub | AHA/ASA Journals
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
The REVIVED-BCIS2 Randomized Trial
Looking at the REVIVED-BCIS2 results, Divaka Perera and C. Michael Gibson discuss the relationship between myocardial viability, PCI, and outcomes.
Dr. Lackland ISC25-19 lowering stroke risk
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division…
Comparison of Fixed Dose Versus Weight-Adjusted Heparin on the Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization
The authors investigated the impact of weight-adjusted heparin doses on the incidence of radial artery occlusion in patients undergoing diagnostic transradial catheterization
California wildfires may increase risk of heart attacks, heart failure, and stroke
Kaiser Permanente study finds variations in impact of air pollution from 2018 Mendocino Complex and Camp fires on cardiovascular health.
Elon Musk’s DOGE team examines Medicare and Medicaid Services – WSJ By Investing.com
Elon Musk’s DOGE team examines Medicare and Medicaid Services – WSJ
New therapies to treat cardiac amyloidosis : Current Opinion in Cardiology
another transthyretin stabilizer, has very recently been FDA-approved following positive results in the ATTRibute-CM trial. Vutrisiran, a transthyretin gene silencer, demonstrated efficacy in the HELIOS-B…
